ArchiMed completes take-private deal of Natus for $1.1bn
As a result of the closing, Natus will no longer trade on the NASDAQ.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
